CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma

Subjects have previously received anthracyclic drug pretreatment;

Hypersensitivity to any study drug or its components;

Uncontrollable systemic diseases (such as advanced infection, uncontrollable hypertension, diabetes, etc.);

Heart function and disease meet one of the following conditions: a) long QTc syndrome or QTc interval >480 ms; b) complete left bundle branch block, grade II or III atrioventricular block; c) Serious and uncontrolled arrhythmias requiring drug treatment; d) New York Heart Association grade ≥ III; e) Cardiac ejection fraction (LVEF) lower than 50%;f) A history of myocardial infarction, unstable angina pectoris, severe unstable ventricular arrhythmia or any other arrhythmia requiring treatment, a history of clinically serious pericardial disease, or ECG evidence of acute ischemia or active conduction system abnormalities within 6 months before recruitment.